Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Zusanli (ST36) Electroacupuncture Treatment for Neoadjuvant Immunotherapy in Non-Small Cell Lung Cancer

NCT07076836 is registered in ClinicalTrials.gov with West China Hospital as lead sponsor.

NCT NCT07076836
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07076836 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Zusanli (ST36) Electroacupuncture Treatment for Neoadjuvant Immunotherapy in Non-Small Cell Lung Cancer
Lead sponsor
West China Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
August 31, 2026
Completion date
June 30, 2028
Enrollment
82 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

electroacupuncture, immune checkpoint blockade, lung cancer (nsclc)